Published: Mar 01, 2024, 24:55 IST | Updated: Mar 01, 2024, 24:55 IST
All is not well with Elon Musk's Neurallink the brain chip startup is facing regulatory scrutiny from the US Food and Drug Administration. According to reports the FDA records have revealed issues at Neurallink's California facility related to record-keeping and quality controls for animal experiments.